Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | Very High | Very High |
Rating | 5.0 | 3.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.4 | 1.86 |
NAV | ₹169.47 | ₹26.03 |
Fund Started | 26 Aug 2010 | 02 Dec 2020 |
Fund Size | ₹66136.11 Cr | ₹4669.44 Cr |
Exit Load | Exit load of 1% if redeemed within 1 year. | Exit load of 1% if redeemed within one year. |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | -7.49% | -4.47% |
3 Year | 23.02% | 18.33% |
5 Year | 32.82% | - |
1 Year
3 Year
5 Year
Equity | 95.16% | 96.34% |
Cash | 4.81% | 3.64% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
---|---|
Multi Commodity Exchange Of India Ltd. | 2.18% |
HDFC Bank Ltd. | 1.91% |
Kirloskar Brothers Ltd. | 1.30% |
Karur Vysya Bank Ltd. | 1.22% |
State Bank of India | 1.20% |
NLC India Ltd. | 1.17% |
Tube Investments Of India Ltd. | 1.17% |
Zydus Wellness Ltd. | 1.16% |
Paradeep Phosphates Ltd. | 1.13% |
Apar Industries Ltd. | 1.11% |
Name | Assets |
---|---|
Multi Commodity Exchange Of India Ltd. | 2.99% |
Karur Vysya Bank Ltd. | 2.25% |
City Union Bank Ltd. | 2.25% |
Aster DM Healthcare Ltd. | 2.18% |
Affle 3I Ltd. | 2.06% |
Navin Fluorine International Ltd. | 1.99% |
Kei Industries Ltd. | 1.98% |
Subros Ltd. | 1.87% |
TD Power Systems Ltd. | 1.84% |
Eris Lifesciences Ltd. | 1.83% |
Name | Akshay Sharma | Nitin Jain |
Start Date | 01 Dec 2022 | 01 Oct 2024 |
Name
Start Date
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related instruments of small cap companies. | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of small cap companies. |
Launch Date | 26 Aug 2010 | 02 Dec 2020 |
Description
Launch Date